Find a Specialist by Postal Code | Page 4 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Navneet Majhail, MD, MS The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Stefanie Thomas, MD Cleveland Clinic Children's Hospital Cleveland Ohio United States
  • Pediatric
Rabi Hanna, MD The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Pediatric
Yogen Saunthararajah, MD The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Jaroslaw Maciejewski, MD, PhD The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aziz Nazha, MD The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Seth Rotz, MD Cleveland Clinic Children's Hospital Cleveland Ohio United States
  • Pediatric
Sudipto Mukherjee, MD, MPH Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Seth Corey, MD, MPH Cleveland Clinic – Lerner Research Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Hetty Carraway, M.D. The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Aaron Gerds, MD, MS The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Uma Borate, MBBS The Ohio State University Comprehensive Cancer Center Columbus Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Alice S. Mims, MD Ohio State University Comprehensive Cancer Center Columbus Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Ramiro Garzon, MD Ohio State University Wexner Medical Center Columbus Ohio United States
  • Acute Myeloid Leukemia (AML)
Stephen Chung, MD UT Southwestern Medical Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Taha Bat, MD UT Southwestern Medical Center Dallas Texas United States
  • Aplastic Anemia
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Robert Collins, MD Harold C. Simmons Comprehensive Cancer Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Yazan F. Madanat, MD UT Southwestern Medical Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Jay Yang, MD Karmanos Cancer Institute Detroit Michigan United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Suresh Balasubramanian Karmanos Cancer Institute Detroit Michigan United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)